Literature DB >> 15054040

Matching at the MHC class I K locus is essential for long-term engraftment of purified hematopoietic stem cells: a role for host NK cells in regulating HSC engraftment.

Yiming Huang1, Francine Rezzoug, Paula M Chilton, H Leighton Grimes, Daniel E Cramer, Suzanne T Ildstad.   

Abstract

The events that regulate engraftment and long-term repopulating ability of hematopoietic stem cells (HSCs) after transplantation are not well defined. We report for the first time that major histocompatibility complex (MHC) class I K plays a critical role in HSC engraftment via interaction with recipient natural killer (NK) cells. Durable engraftment of purified HSCs requires MHC class I K matching between HSC donor and recipient. In the absence of MHC class I K matching, HSCs exhibit impaired long-term engraftment (P =.01). Dependence on MHC class I K matching is eliminated in B6 beige mice that lack NK cell function, as well as in wild-type mice depleted of NK cells, implicating a possible regulatory role of NK cells for HSC engraftment. The coadministration of CD8+/T-cell receptor-negative (TCR-) graft facilitating cells (FCs) matched at MHC class I K to the HSC donor overcomes the requirement for MHC class I K matching between HSCs and recipient. These data demonstrate that FCs inhibit NK cell effects on the HSCs. Notably, FCs do not suppress the cytotoxic activity of activated NK cells. Enhanced green fluorescent protein-positive (EGFP+) FCs persist for one month following allogeneic transplantation, making cold target inhibition an unlikely mechanism. Therefore, MHC class I may play a critical role in the initiating events that dictate HSC engraftment and/or NK-mediated rejection following allogeneic transplantation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15054040     DOI: 10.1182/blood-2003-11-3910

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  14 in total

1.  The role of pDC, recipient T(reg) and donor T(reg) in HSC engraftment: Mechanisms of facilitation.

Authors:  Paul A Cardenas; Yiming Huang; Suzanne T Ildstad
Journal:  Chimerism       Date:  2011-07-01

2.  Humoral immunity is the dominant barrier for allogeneic bone marrow engraftment in sensitized recipients.

Authors:  Hong Xu; Paula M Chilton; Michael K Tanner; Yiming Huang; Carrie L Schanie; Mariano Dy-Liacco; Jun Yan; Suzanne T Ildstad
Journal:  Blood       Date:  2006-08-03       Impact factor: 22.113

Review 3.  Hematopoietic stem and progenitor cells directly participate in host immune response.

Authors:  Olusola Jumoke Daramola; Stephen Osasan; Hebah Ali; Perpetua Emeagi
Journal:  Am J Stem Cells       Date:  2021-06-15

4.  In vivo imaging of Treg cells providing immune privilege to the haematopoietic stem-cell niche.

Authors:  Joji Fujisaki; Juwell Wu; Alicia L Carlson; Lev Silberstein; Prabhakar Putheti; Rafael Larocca; Wenda Gao; Toshiki I Saito; Cristina Lo Celso; Hitoshi Tsuyuzaki; Tatsuyuki Sato; Daniel Côté; Megan Sykes; Terry B Strom; David T Scadden; Charles P Lin
Journal:  Nature       Date:  2011-06-08       Impact factor: 49.962

5.  CD8α+ plasmacytoid precursor DCs induce antigen-specific regulatory T cells that enhance HSC engraftment in vivo.

Authors:  Yiming Huang; Larry D Bozulic; Thomas Miller; Hong Xu; Lala-Rukh Hussain; Suzanne T Ildstad
Journal:  Blood       Date:  2010-12-29       Impact factor: 22.113

Review 6.  Stem cell-based therapeutic applications in retinal degenerative diseases.

Authors:  Yiming Huang; Volker Enzmann; Suzanne T Ildstad
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

7.  Innate and adaptive immune responses are tolerized in chimeras prepared with nonmyeloablative conditioning.

Authors:  Hong Xu; Ziqiang Zhu; Yiming Huang; Larry D Bozulic; Lala-Rukh Hussain; Jun Yan; Suzanne T Ildstad
Journal:  Transplantation       Date:  2012-03-15       Impact factor: 4.939

8.  Evidence that FoxP3+ regulatory T cells may play a role in promoting long-term acceptance of composite tissue allotransplants.

Authors:  Larry D Bozulic; Yujie Wen; Hong Xu; Suzanne T Ildstad
Journal:  Transplantation       Date:  2011-04-27       Impact factor: 4.939

9.  Busulfan produces efficient human cell engraftment in NOD/LtSz-Scid IL2Rgamma(null) mice.

Authors:  Jun Hayakawa; Matthew M Hsieh; Naoya Uchida; Oswald Phang; John F Tisdale
Journal:  Stem Cells       Date:  2009-01       Impact factor: 6.277

10.  Characterization of Human CD8(+)TCR(-) Facilitating Cells In Vitro and In Vivo in a NOD/SCID/IL2rγ(null) Mouse Model.

Authors:  Y Huang; M J Elliott; E S Yolcu; T O Miller; J Ratajczak; L D Bozulic; Y Wen; H Xu; M Z Ratajczak; S T Ildstad
Journal:  Am J Transplant       Date:  2015-11-09       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.